Drug recall · October 3, 2012
Fentanyl Transdermal System recall
Why: Subpotent; some patches may not contain fentanyl gel
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc.
- Lots / codes
Lot number 455040A (carton) 455040 (pouch)
- Quantity
- 98,088 cartons (5 pouches per carton)
- Company
- Actavis, Salt Lake City, UT
- Distribution
- Nationwide
- Initiated
- July 11, 2012 · Voluntary: Firm initiated
- Classified
- September 25, 2012
- Reported
- October 3, 2012
- Ended
- April 10, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fentanyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.